The Evaluation of Safety and Tolerance of Commercially Available Naltrexone Administered Daily - Assessment for CBRN Operations

NCT03879460 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

OTHER_GOV

Sponsor class

Conditions

Opioid Intoxication

Interventions

DRUG: Naltrexone Hydrochloride

Sponsor

Timothy Smith